A detailed history of Stone X Group Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Stone X Group Inc. holds 5,232 shares of BSX stock, worth $537,274. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,232
Previous 5,912 11.5%
Holding current value
$537,274
Previous $635 Million 19.56%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$97.03 - $108.14 $65,980 - $73,535
-680 Reduced 11.5%
5,232 $511 Million
Q2 2025

Aug 13, 2025

BUY
$89.7 - $107.41 $28,883 - $34,586
322 Added 5.76%
5,912 $635 Million
Q1 2025

Aug 13, 2025

SELL
$89.38 - $106.18 $22,523 - $26,757
-252 Reduced 4.31%
5,590 $564 Million
Q4 2024

Aug 13, 2025

BUY
$83.62 - $91.5 $488,508 - $534,543
5,842 New
5,842 $522 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.